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SUMMARY 16 
TIR (Toll/interleukin-1 receptor/resistance protein) domains feature in animal, plant and bacterial 17 
proteins involved in innate immunity pathways and associated processes. They function through 18 
protein:protein interactions, in particular self-association and homotypic association with other TIR 19 
domains. Structures of TIR domains from all phyla have been determined, but common association 20 
modes have only emerged for plant and bacterial TIR domains, and not for mammalian TIR 21 
domains. Numerous attempts involving hybrid approaches, which have combined structural, 22 
computational, mutagenesis and biophysical data, have failed to converge onto common models of 23 
how these domains associate and function. We propose that the available data can be reconciled in 24 
the context of higher-order assembly formation, and that TIR domains function through signaling 25 
by cooperative assembly formation (SCAF). 26 
 27 
28 
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INTRODUCTION 29 
The TIR (Toll/interleukin-1 receptor (IL-1R)/resistance protein) domain was first defined after 30 
detecting sequence similarities between the intracellular regions of the mammalian IL-1R and 31 
the Drosophila protein Toll [1]. TIR domains typically function as protein interaction modules, and 32 
are mostly found in multi-domain proteins involved in innate immunity pathways in animals and 33 
plants, despite the proposed independent evolutionary origins for these pathways [2]. TIR domains 34 
also appear in many bacterial proteins, at least some of which are used by pathogenic bacteria to 35 
evade the host immune responses [3].  36 
 In mammals, TIR domains are found in Toll-like receptors (TLRs) and IL-1Rs as their 37 
cytosolic segments, as well as in the cytosolic adaptor proteins involved in signaling downstream 38 
from these receptors. TLRs (10 family members in humans: TLR1-10) are pattern-recognition 39 
receptors (PRRs) that defend against microbial infection and endogenous danger, by interacting 40 
with conserved pathogen- and danger-associated molecular patterns (PAMPs/DAMPs) [4]. These 41 
interactions lead to the TLR-selective recruitment of the TIR domain-containing adaptor proteins 42 
MyD88, MAL (TIRAP), TRIF (TICAM-1) and TRAM (TICAM-2) via TIR:TIR domain 43 
interactions [5]; these interactions trigger downstream activation of transcription factors such as 44 
NF-κB, AP-1 and IRFs to induce anti-pathogen signaling and inflammation [6]. An atypical TLR 45 
adaptor is SARM, which acts as a negative regulator of TRIF signaling [7], but also functions in 46 
neuronal axon degeneration [8,9] and cell-death pathways [10]. BCAP (B-cell adaptor for PI3K) 47 
has recently been proposed to be the sixth TIR domain-containing TLR adaptor [11,12]. IL-1Rs (10 48 
family members found in humans: IL-1RI, IL-1RII, IL-1RaCP, ST-2, IL-1Rrp, IL-1Rrp2, IL-49 
1RAcPL, IL-1RAPL, IL-1RAPL2 and SIGIRR) associate with proinflammatory cytokines, and like 50 
some of their TLR cousins, signal by recruiting the TIR domain-containing adaptor MyD88 [13]. 51 
 In plants, TIR domains are found as the N terminal segments of a major subclass of 52 
cytoplasmic nucleotide-binding (NB)/leucine-rich repeat (LRR) resistance (R) proteins. NB-LRR 53 
proteins are typically referred to as plant NLRs due to their similarity to mammalian nucleotide-54 
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binding oligomerization domain (NOD)-like receptors [14]. Plant NLRs directly or indirectly 55 
recognize "effector" proteins introduced into the plant cell by plant pathogens during the invasion 56 
of the plant. Effector detection by plant NLRs triggers defense responses, known as the 57 
hypersensitive response, that often include localized cell death at the site of infection [15]. The TIR 58 
domains are considered to be the signaling domains in plant NLRs, because they can cause cell 59 
death autonomously when expressed ectopically in planta [16-18]. TIR-only (TIR-X) and TIR-NB 60 
(TIR-N) proteins are also found in plants [19], and while their general functions are to date 61 
unknown, a number of these proteins have been shown to induce cell death when transiently 62 
expressed in tobacco and provide enhanced resistance when overexpressed in stable transgenics in 63 
Arabidopsis [20].  64 
 TIR domains are also found in proteins from a wide range of bacterial species, where they 65 
exist in combination with different types of domains [3]. Although the functions of most of these 66 
proteins are unknown, some proteins such as TcpB from Brucella melitensis and TcpC from 67 
uropathogenic Escherichia coli CFT073 suppress TLR signaling, possibly through interacting with 68 
the host TIR domain-containing proteins [21]. 69 
  In all these different organisms, TIR domains are thought to function through self-70 
association and homotypic association with other TIR domains. However, they can also engage in 71 
heterotypic interactions with proteins not containing TIR domains (e.g. the vaccinia virus protein 72 
A46 can bind MyD88, MAL, TRIF, TRAM and TLR4 [22]), and in intramolecular fashion with 73 
other domains in TIR domain-containing proteins [14] (e.g. with both the NB and LRR domains in 74 
the plant NLR RPP1 [23], and with an N-terminal helix in the bacterial protein TcpB [24]).  75 
 Currently, 32 structures corresponding to 16 different TIR domains from animals, plants and 76 
bacteria have been deposited in the Protein Data Bank [25]. Structurally, TIR domains comprise 77 
125-200 residues and contain a central parallel β-sheet surrounded by α-helices [25,26]. The 78 
elements of secondary structure are usually referred to sequentially; for example the BB loop 79 
connects strand !B with helix "B. Some of these structural elements correspond to conserved 80 
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sequence motifs called box 1–3 in mammalian TIR domains [25]. While the wealth of structural 81 
information has improved our understanding of TIR-domain function in individual systems, it is 82 
widely assumed that TIR-domain functions in different systems do not converge on a common 83 
mechanism of action. To date, no common self-association interfaces have been observed in the 84 
crystal structures of animal TIR domains, and numerous studies combining structural knowledge of 85 
TIR domains with computational docking, site-directed mutagenesis and other methods have 86 
proposed models that are different from each other [27-48]. By contrast, some common association 87 
modes are emerging for plant and bacterial TIR domains. Here, we review the key studies 88 
attempting to define the structural basis of TIR-domain function and suggest that both in plant and 89 
mammalian innate immunity pathways, it could be explained in the context of signaling by 90 
cooperative assembly formation (SCAF) (Box 1). 91 
 92 
2. SELF-ASSOCIATION AND HOMOTYPIC ASSOCIATION OF TIR DOMAINS IN MAMMALIAN PROTEINS 93 
TLR and IL-1R-dependent signal transduction is initiated by self-association of their intracellular 94 
TIR domains (hereafter denoted with superscript "TIR") upon binding of PAMPs (TLRs) or 95 
cytokines (IL-1Rs). The TLRTIR dimer then acts as a scaffold to recruit downstream adaptor 96 
proteins through TIR:TIR domain interactions. The highly conserved BB-loop in TLR/IL-1R and 97 
adaptor TIR domains plays an important role in signaling. In TLR4, the BB loop is the site of a 98 
naturally occurring mutation P712H [49], which renders it non-responsive to the PAMP 99 
lipopolysaccharide (LPS). This mutation also abolishes signaling when introduced into other 100 
receptor or adaptor TIR domains. 101 
 MyD88 also contains a death domain (DD) that interacts with IRAKs (IL-1R-associated 102 
kinases) through DD:DD interactions, forming the oligomeric myddosome, consisting of six 103 
MyD88, four IRAK4 and four IRAK2 DDs [50] (Box 1c). Forced dimerization of MyD88TIR 104 
constitutively initiates signaling [51], suggesting that upon TLR activation, the TLR, MAL and 105 
MyD88 form an oligomeric platform through TIR:TIR domain interactions, which in turn promotes 106 
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the assembly of the myddosome via DD:DD interactions. In comparison to MyD88 signaling, less 107 
is known about TRIF signaling, but live-cell imaging and confocal immunofluorescence analyses 108 
have shown that TRIF alters its distribution profile from a diffuse cytoplasmic to a speckle-like 109 
structure in response to TLR3 interaction with dsRNA [52], suggesting the formation of TIR 110 
domain-dependent oligomeric TRIF complexes.   111 
 Crystal structures have been determined for the TIR domains of human TLR1, TLR2, 112 
TLR6, TLR10, IL-1RAPL, MAL, MyD88 [26,30,37,40-43,53] and Toll-related receptor TRR-2 113 
from the lower metazoan Hydra magnipapillata (PDB ID 4W8G, 4W8H). NMR structures have 114 
also been determined for MyD88TIR, TRAMTIR and TRIFTIR [32,36]. Attempts to form stable TIR-115 
domain complexes have been unsuccessful, suggesting that weak interactions are a general feature 116 
of the mammalian TIR-domain complexes, and that membrane localization or the context of a large 117 
assembly stabilizes the interactions. Crystal contacts can reflect biological interactions [54]; 118 
analyses of crystal structures and combinations of computational modeling and docking studies, 119 
NMR and site-directed mutagenesis have led to several models of TIR domain assembly and 120 
although they are all different from each other [27-48], some common trends in the proposed 121 
TIR:TIR domain interaction modes are emerging (Figure 1, Table S1). 122 
 The BCD interface. Several of the crystal structures (TLR1, TLR2, TLR6, IL-RAPL, MAL 123 
and TRR-2) contain an interface involving the αC helices and either the αB/BB-loops or the αD 124 
regions, or both (the BCD interface) (Figure 1). In the TLR1TIR, TLR2TIR and TLR6TIR structures, 125 
symmetric αC:αC helix interactions are found at the core of this interface, flanked on both sides by 126 
interactions between the BB-loop/αB region on one molecule and the DD-loop/αD region on the 127 
second molecule [26,43]. It has been questioned whether this interface is physiologically relevant, 128 
because in both TLR1 and TLR6, it is stabilized by a disulfide bond (between the C707 residues in 129 
TLR1 and the equivalent C712 residues in TLR6). However, a similar interface involving the same 130 
secondary structure elements is also observed in the IL-1RAPL crystal structure [30]. In the 131 
TLR10TIR dimer [40], one of the molecules has been rotated 90° compared to the TLR1TIR, TLR2TIR 132 
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and TLR6TIR dimers, resulting in the two BB loops of TLR10TIR interacting directly with each 133 
other. Many loss-of-function mutations in TLR4 localize to the surface regions involved in this 134 
interface and the TLR10TIR homodimer has therefore been widely accepted as representative of 135 
TLR4TIR dimerization following LPS recognition [27-29,31,36]. 136 
 Crystal-contact analysis of the MAL structures revealed a symmetric interface comprising 137 
the αC and αD regions. Mutations of residues in this interface disrupt both MAL and MyD88 138 
binding [37,41]. In one of the crystal forms of TRR-2TIR (PDB ID 4W8G), one of the molecules has 139 
been rotated 180° compared to the MAL dimer, and the interface consists of the αC and αD helices 140 
of one molecule and the αC and αB helices of the second molecule. Although significant 141 
differences are observed between the interfaces described here, they are all centered around the αC 142 
helix and involve similar faces of the TIR domain. Furthermore, docking of TRAMTIR NMR 143 
structures, using data based on mutagenesis coupled with yeast-two-hybrid (Y2H) assays as 144 
restraints, suggested that TRAMTIR can self-associate using a similar configuration to the TLR10TIR 145 
dimer [36], while MyD88TIR can self-associate via a MALTIR-like dimer interface [35]. 146 
 The BE interface. The MyD88TIR crystal structure and the two different crystals forms of 147 
TRR-2TIR contain an asymmetric head-to-tail TIR:TIR domain interaction involving the BB-loop of 148 
one molecule and the surface encompassing the βE/EE loop/αE region of the second molecule (the 149 
BE interface; Figure 1c). Extensive mutagenesis using the mammalian-two-hybrid (MAPPIT) 150 
methodology combined with docking also provides support for an asymmetric BE interface 151 
involved in MyD88 self-association [35]. Furthermore, site-directed mutagenesis data identify both 152 
the BB-loop (R196/D197) and helix αE (K282/R288) as MAL-binding sites, suggesting that 153 
MALTIR and MyD88TIR may interact through a similar head-to-tail mode [32]. 154 
 Some lines of evidence suggest that purified TLR adaptor TIR domains may form higher-155 
order oligomers at high protein concentrations. For example, the 15N-labeled signals from 156 
MyD88TIR uniformly decreased upon titration with MALTIR [32]. Furthermore, TRAM and TRIF 157 
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oligomerized and precipitated out of solution at concentration above 200 µM [36]. Precipitation was 158 
prevented by the introduction of a BB-loop mutation (C117H in TRAM and P434H in TRIF), 159 
which has previously been shown to disrupt self-association in Y2H assays and to have a dominant 160 
negative effect in IFN-β reporter assays; this enabled the NMR structures of the monomeric 161 
proteins to be determined. 162 
 Many of the TIR-domain assembly models have assumed a 2:1 or 1:1 receptor/adaptor 163 
TIR:TIR domain stoichiometry [27,28,31], but more recent models try to rationalize how a single 164 
TLRTIR dimer can recruit >6 MyD88 molecules required for myddosome assembly.  In one study 165 
[29], the PRISM algorithm combined with existing crystal structures and experimental data was 166 
used to model MyD88 and TRIF signalosomes. Several different plausible models are presented, 167 
but it is argued that the most likely is a model consisting of a symmetric BCD-interface TLR4 168 
dimer (similar to the TLR10TIR dimer) that interacts with two symmetric BCD-interface MAL 169 
dimers, which in turn recruit two symmetric MyD88 dimers; this would result in clustering of 8 170 
MyD88 DDs, enabling myddosome formation. A completely different model, based on MAPPIT 171 
mutagenesis data and docking, is presented in another study [35], where it is proposed that MyD88 172 
oligomerization is a result of self-association through both a symmetric BCD interface (similar to 173 
the MALTIR crystal dimer) and an asymmetric BE interface . By combining the two types of 174 
interactions, it is proposed that MyD88TIR molecules can assemble into a left-handed helix, bringing 175 
the DDs together for myddosome assembly. This model displays similarities to the open-ended 176 
pyrin domain (PYD)/CARD assemblies recently described for other innate immunity pathways (e.g. 177 
the inflammasomes [55] and MAVS-dependent RIG-I/MDA-5 signaling [56]), and extension of the 178 
left-handed helix would presumably enable a single TLR dimer to assemble multiple myddosomes, 179 
which is consistent with the ability of TLRs to activate a large transcriptional response based on 180 
extremely low concentrations of PAMPs. Although this model is consistent with observed TIR:TIR 181 
domain interaction modes, the observed variations could give rise to different oligomeric TIR-182 
domain architectures. For example, in one of the TRR-2 crystal forms (PDB ID 4W8G), we also 183 
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observe a combination of BCD and BE interfaces, which results in a formation of a linear parallel 184 
two-stranded head-to-tail array of TIR domains within the crystal (Figure 1d). This architecture 185 
would also enable MyD88 DD clustering and myddosome formation. The BCD interface in this 186 
linear assembly differs from the MAL-based BCD interface in [35] by a 180° rotation of one of the 187 
molecules. However, it involves the αC and αD helices and can thus explains the reported MyD88 188 
mutagenesis data. Our analyses illustrate that care must be used in interpreting docking results with 189 
limited structural information, and to fully elucidate the molecular mechanisms of TIR-domain 190 
assembly formation and the exact nature of the interfaces, structural information on stable 191 
oligomeric assemblies will be required. Furthermore, TIR-domain proteins usually contain other 192 
domains and can be attached to membranes; however, the TIR-domain linker sequences are usually 193 
of sufficient length (>20 residues) to enable the proposed interactions on cell-membranes  or in the 194 
presence of other domains. 195 
 196 
3. SELF-ASSOCIATION AND HOMOTYPIC ASSOCIATION OF TIR DOMAINS IN PLANT PROTEINS 197 
The Arabidopsis TIR-X protein AtTIR (AT1G72930) provided the first plant TIR-domain structure 198 
[57]. It revealed a similar fold to those observed for mammalian TIR domains; however, an 199 
extended αD region is found. This feature appears to be unique to the plant TIR domains and 200 
present in most, but not all. AtTIR was report to be monomeric in solution [57]; however, this data 201 
was inferred from size-exclusion chromatography (SEC) alone, which, as subsequent studies have 202 
revealed, is unlikely to detect transient self-association. The first TIR-domain structure from a plant 203 
NLR came from the flax protein L6. L6TIR can self-associate according to Y2H and in-solution 204 
assays (SEC/multi-angle laser light scattering (MALS) and analytical ultracentrifugation (AUC)) 205 
[17]. Crystal-contact analysis, combined with mutagenesis, in-solution self-association assays and 206 
Y2H assays, revealed that the αD1/3, βE and αE regions mediate L6TIR self-association (the DE 207 
interface; Figure 2a, Table S1). Self-association is linked to the cell death-inducing activity 208 
association of L6TIR [17]. 209 
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The RPS4TIR:RRS1TIR complex is the only crystal structure available for a complex of two 210 
different TIR domains. RPS4 and RRS1 are jointly responsible for NLR-mediated resistance to 211 
three different pathogens in Arabidopsis. The regions that mediate the heterodimer interaction (αA, 212 
αE and the AA and EE loops - the AE interface) are also observed in the structures of RRS1TIR, 213 
RPS4TIR and AtTIR as individual proteins [18]. RPS4TIR, but not RRS1TIR can induce cell-death 214 
signaling responses. The AE interface has been recently also observed in the crystal structures of 215 
the TIR domains from the wild grape NLR RPV1 [58] and the Arabidopsis NLRs SNC1 [59,60] 216 
and RPP1 [60].  217 
The self-association of plant TIR domains observed to date is weak and transient; the 218 
dissociation constants measured for L6TIR and RPS4TIR by AUC experiments are in the high µM 219 
range. RPV1TIR did not appear to self-associate in vitro under the conditions tested. It is speculated 220 
that TIR:TIR domain interactions would be stabilized, in the activated NLRs, by self-association of 221 
other domains such as the NB domains, based on comparisons with the related mammalian NLRs 222 
[14]. By contrast, the heterodimer formed between RPS4TIR:RRS1TIR is ~100x stronger (455 nM) 223 
than any self-associations of plant TIR domains. RRS1TIR suppresses RPS4TIR cell-death signaling 224 
in plants and suggests that the RPS4TIR:RRS1TIR interaction represents a repressed state of the pair 225 
[18].  226 
The interfaces that mediate self-association in L6TIR and RPS4TIR are distinct, but they could 227 
co-exist (Figure 2). Mutations in Arabidopsis RPP1TIR that map to both the DE and AE interfaces 228 
affect RPP1TIR self-association, and a correlation between the degree of self-association in vitro and 229 
cell-death signaling has been observed [23]. These data suggest that both interfaces may facilitate 230 
self-association and signaling in RPP1 and potentially other plant TIR domains. Recent structures 231 
of SNC1TIR and RPP1TIR [59,60] revealed both AE and DE self-association interfaces within the 232 
crystal structures. Both interfaces also appear to control self-association, and we speculate that these 233 
interfaces may facilitate SCAF in the plant TIR domains (Figure 2). 234 
 235 
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4. SELF-ASSOCIATION AND HOMOTYPIC ASSOCIATION OF TIR DOMAINS IN BACTERIAL PROTEINS 236 
A common self-association interface has been observed in the available crystal structures of 237 
bacterial TIR domains, PdTLPTIR from the non-pathogenic Paracoccus denitrificans [61] and TcpB 238 
from the pathogenic Brucella melitensis [24,53,62] (Figure 3, Table S1). The dimer interfaces in 239 
both involve the DD and EE loops (different interface than the DE interface in plant TIR-domains) 240 
and leave the BB loops exposed on the surface of the molecules. While TcpBTIR associates 241 
transiently, full-length TcpB forms a stable dimer [62] and in one of the crystal structures, a helix 242 
corresponding to the sequence N-terminal to the TIR domain has been found to stabilize the 243 
interaction [24]. PdTLP and TcpB, as well as a number of other bacterial TIR-domain proteins, 244 
interact with MyD88, and some have been shown to interact with other mammalian TIR domains, 245 
including MALTIR and TLR4TIR, and interfere with NF-κB signaling [21,42,62].  246 
 247 
5. RECONCILIATION OF STRUCTURAL DATA IN THE CONTEXT OF HIGHER-ORDER ASSEMBLY 248 
FORMATION 249 
While common trends in association modes are emerging in plant and bacterial TIR domains, this is 250 
still not the case in animal TIR domains, despite the more extensive research. What could be the 251 
possible reasons for this? For the domains functional in innate immunity signaling, the associations 252 
need to be weak by design, so that responses are not too easily triggered in the absence of a 253 
pathogen or danger inducer. The specific conditions required for crystallization may therefore easily 254 
destabilize these interactions. Furthermore, the domains may have a tendency to assemble into 255 
higher-order oligomers not compatible with crystal formation. Indeed, higher-order assembly is an 256 
emerging feature of signaling in diverse innate immunity pathways. Protein domains from the DD 257 
family, in particular, appear to be able to form large, often open-ended helical structures [63,64]. 258 
Signaling through cooperative assembly formation (SCAF) explains the ultrasensitive, all-or-none 259 
response that is required in immune responses.  260 
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 We propose that the available data on TIR-domain interactions can be reconciled by the 261 
hypothesis that TIR domains that function in immunity pathways signal by cooperative assembly 262 
formation (SCAF). The structures available to date likely provide snapshots into this assembly, but 263 
the structures may, for reasons outlined above, vary in their biological relevance. Reconstitution of 264 
stable complexes and their structural analysis, in combination with complementary cell biology 265 
approaches, should reveal the interactions relevant to the signalosomes that occur in vivo.  266 
  267 
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FIGURE LEGENDS 485 
 486 
Box 1. (a) In the classical concept of receptor-mediated signaling, the activated receptor (R; for 487 
example, activated by binding to the ligand L, blue) initiates signal transduction inside the cell 488 
through successive steps of activation of signaling proteins (E; for example, enzymes that perform 489 
post-translational modifications, such as protein kinases, or enzymes that produce second 490 
messengers, such as adenylyl cyclases). This leads to signal amplification in a cascade-like fashion. 491 
Red and green represent inactive and activated proteins, respectively. (b) In the case of signaling by 492 
cooperative assembly formation (SCAF), the activated receptor initiates signal transduction through 493 
higher-order assembly formation, which involves cooperative interactions with adaptor proteins (A) 494 
and eventually enzymes (E) to form a signalosome. The large assembly can lead to rapid activation 495 
of enzymes such as protein kinases or proteases through proximity-induced activation. The 496 
cooperativity is the result of conformational changes and new binding sites generated by the 497 
assembly architecture. SCAF appears to operate in most innate immunity pathways, including the 498 
ones involving TIR domains. Most higher-order assemblies characterized to date are mediated by 499 
members of the death-domain (DD) fold (DD, CARD, PYD, death-effector domain). The DD-500 
mediated helical assembly containing 6 MyD88 (shades of red), 4 IRAK4 (shades of green) and 4 501 
IRAK2 (shades of blue) DDs [50] is shown as an example in (c) in cartoon representation. 502 
 503 
 504 
Figure 1.  Representative TIR:TIR domain interactions based on structures of mammalian TIR 505 
domains.  506 
(a) Crystal contact-based TIR-domain dimers [26,30,37,40,43] (PDB ID 4W8H). The protomers 507 
depicted on the right are all shown in analogous orientations.  508 
(b) Superposition of one of the protomers from all the dimers shown in (a). The superimposed 509 
protomer of the TLR2TIR is shown in surface representation), with the other protomer from all the 510 
- 24 - 
TIR  domains  shown in different colors in ribbon representation. 511 
(c) Head-to-tail arrangement of TIR domains in the crystals of MyD88TIR [42] and TRR2TIR (PDB 512 
ID 4W8G and  4W8H).  513 
(d) Two stranded parallel head-to-tail arrangement of TIR domains in the crystals of TRR2TIR (PDB 514 
ID 4W8G). 515 
 516 
 517 
Figure 2. TIR:TIR domain interactions mediated by the DE and AE interfaces in plant TIR-domain 518 
proteins. 519 
(a) Crystal contact-based TIR-domain dimers observed for the L6TIR (blue) [17] and the 520 
heterodimer of RPS4TIR (dark green) and RRS1TIR (green) [18], revealing the DE and AE interfaces, 521 
respectively.  522 
(b) Superimposed RPS4TIR and L6TIR dimers, revealing that the DE and AE interface can coexist. 523 
(c) A hypothetical AE and DE interface-mediated assembly of plant TIR domains (individual 524 
domains are shown in different colours). Note that this model does not account for other domains in 525 
NLR proteins, such as the NB and LRR domains, which could influence the arrangement and 526 
stoicometry of predicted assembles of plant NLRs, based on comparisons with the related 527 
mammalian NLRs [14].  528 
 529 
 530 
Figure 3. TIR:TIR domain interactions in bacterial TIR-domain proteins. The crystal structures of 531 
PdTLPTIR (red) [61] and TcpBTIR (blue) [24] reveal an analogous dimer interface. In one of the 532 
structures of TcpBTIR (PDB ID 4LZP) [24], the dimer is stabilized by a helix corresponding to the 533 
sequence N-terminal to the TIR domain (light blue). 534 
 535 
  536 
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Table S1  537 
 538 
Reports on the characterization of homotypic TIR-domain interactions. Only binary 539 
interactions are listed in the table in cases where higher-order complexes have been analyzed in the 540 
original publications.  541 
 542 
Interacting TIR 
domains Organism 
Interface and 
interaction 
mode 
Methods Reference 
Animal TIR domains 
TLR2TIR-
C713S:TLR2TIR-C713S Homo sapiens 
Asymmetric 
dimer; involves 
αB, αC, αD, CD 
and DD 
(molecule A) 
and αB and BB 
(molecule B) 
X-ray 
crystallography, 
mutagenesis 
[33] 
IL-1RAPLTIR:IL-
1RAPLTIR Homo sapiens 
Symmetric 
dimer; involves 
αB, αC and αD 
X-ray 
crystallography, 
mutagenesis 
[30] 
TLR2TIR: MyD88TIR 
Homo sapiens 
Involves BB 
and αA of both 
molecules Computational 
docking, mutagenesis [39] TLR2TIR:TLR2TIR,  
MyD88TIR:MyD88TIR 
Symmetric 
dimer; involves 
αE 
TLR1TIR:TLR2TIR Homo sapiens 
Two interacting 
regions; region 
I: involves 
TLR1 BB, 
TLR2 DD; 
region II: 
involves TLR1 
αA (His646)  
and αC, TLR2 
CD (Asn700) 
Mutagenesis, 
computational 
docking 
[44] 
TLR4TIR:TLR4TIR Homo sapiens 
Symmetric 
dimer; involves 
BB 
Modeling, docking, 
mutagenesis [31] 
TLR10TIR:TLR10TIR Homo sapiens 
Symmetric 
dimer; involves 
BB, DD, αB 
and αC 
X-ray 
crystallography, 
mutagenesis 
[40] 
MyD88TIR:MALTIR Homo sapiens 
Two interacting 
sites on MyD88  
(site 1 
corresponds to 
BB (R196) and 
site 2 to αE 
NMR spectroscopy, 
mutagenesis, docking  [32] 
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(R288) 
TLR4TIR:TLR4TIR 
Homo sapiens 
Symmetric 
dimer: involves 
BB, DD, αC 
Computational 
docking and modeling  [45] 
TLR7TIR:TLR7TIR 
Asymmetric 
dimer: involves 
BB (molecule 
A), αE 
(molecule B) 
MyD88TIR:MyD88TIR 
Symmetric 
dimer: involves 
BB,  αC 
TLR4TIR:SIGIRRTIR 
3 patches; patch 
1:  involves 
TLR4 CD, and 
BB, SIGIRR 
αB; patch 2: 
involves TLR4 
αB and αC, 
SIGIRR αC; 
patch 3: 
involves  TLR4 
BB, SIGIRR 
αD 
TLR7TIR:SIGIRRTIR 
Involves 
SIGIRR BB and 
αB, TLR7 αE, 
CD, βD, βE and 
DE 
MyD88TIR:SIGIRRTIR 
Involves 
MyD88 BB, 
and αC, 
SIGIRR BB, 
AA and αC 
MALTIR:MALTIR 
Homo sapiens 
Symmetric 
dimer: involves 
αC, αD X-ray 
crystallography, 
docking, mutagenesis 
[37] 
MALTIR:MyD88TIR 
Involves MAL 
D96 (AA) and 
S180 (DD), 
MyD88 R196 
(BB) 
TLR4TIR:TLR4TIR 
Homo sapiens 
Symmetric 
dimer: involves 
BB, αC Molecular dynamics (MD) simulations, 
molecular docking  
[46] 
TLR2TIR:TLR1TIR 
Asymmetric 
dimer:  involves 
TLR2 DD, 
- 27 - 
TLR1 BB 
TLR2TIR:TLR6TIR Involves TLR2 DD, TLR6 BB 
ST2LTIR:MALTIR 
Involves ST2L 
AB and BB, 
MAL BB,  βA 
and βB 
ST2LTIR:MyD88TIR 
Involves ST2L 
BB, AA and 
αA, MyD88 
BB, αA 
MALTIR:MALTIR Homo sapiens 
Symmetric 
dimer: involves 
αC, αD 
X-ray 
crystallography, 
mutagenesis 
[41] 
TLR4TIR:TLR4TIR 
Homo sapiens 
Symmetric 
dimer: involves 
BB, DD, αC  
Mammalian protein-
protein interaction 
trap (MAPPIT), 
homology modeling, 
mutagenesis 
[28] 
TLR4TIR:MALTIR, 
TLR4TIR:TRAMTIR 
Involves TLR4 
αA, αB, BB, BC  
MALTIR:MALTIR Homo sapiens 
Asymmetric 
dimer: involves 
DD, DE, αD 
(molecule A), 
N-terminal 
region 
(molecule B) 
X-ray crystallography [47] 
MALTIR:MALTIR 
Homo sapiens 
Symmetric 
dimer: involves 
αC, αD 
Random mutagenesis, 
MAPPIT [27] 
MALTIR:MyD88TIR 
Involves MAL 
AB loop and 
two surface 
areas (area 1: 
Q135, W156; 
area 2: Y195, 
R215) 
MALTIR:TLR4TIR 
Involves MAL 
AB loop  and 
three surface 
areas (area 1: 
Q135, W156; 
area 2: Y195,  
R215; area 3: 
Q153, R184, 
R192) 
TRAMTIR:TRAMTIR Homo sapiens 
Symmetric 
dimer: involves  
BB, αC 
NMR spectroscopy, 
mutagenesis, docking  [36] 
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MyD88TIR:MyD88TIR Homo sapiens 
Symmetric 
dimer: involves 
βA, AA, αA, 
AB, CD, BB, 
αC 
Site-directed 
mutagenesis, 
computational 
modeling  
[48] 
MyD88TIR:MyD88TIR Homo sapiens 
Two 
asymmetric 
dimers: dimer 1 
involves αC, αD 
(molecule A), 
αA, EE and αE 
(molecule B); 
dimer 2 
involves αB, 
BB (molecule 
A), DD, αD, EE 
and αE 
(molecule B) 
X-ray crystallography  [42] 
MALTIR:MALTIR Homo sapiens 
Symmetric 
dimer: involves 
αC, αD 
X-ray 
crystallography, 
mutagenesis 
[53] 
TLR6TIR:TLR6TIR Homo sapiens 
Symmetric 
dimer: involves 
CD, DD, αB αC 
X-ray 
crystallography, 
MALS 
[43] 
TLR4TIR:TLR4TIR 
Homo sapiens 
Two symmetric 
dimers; both 
involve BB 
Modeling, in silico 
mutagenesis  [29] MAL
TIR:MALTIR 
Symmetric 
dimer: involves 
AB 
TRAMTIR:TRAMTIR 
Symmetric 
dimer: involves 
BB 
ST2TIR:TLR4TIR, 
ST2TIR:TRIFTIR Homo sapiens Involves BB 
Modeling, in silico 
mutagenesis  [38] 
MyD88TIR:MyD88TIR Homo sapiens 
Asymmetric 
dimer: involves 
BB (molecule 
A), αE 
(molecule B); 
symmetric 
dimer:  involves 
αD, αC 
MAPPIT, 
mutagenesis, docking [35] 
TLR4TIR:TLR4TIR Mus musculus 
Asymmetric 
dimer: involves 
BB  (molecule 
A), αE 
(molecule B) 
Decoy peptides, 
modeling  [34] 
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TRR-2TIR:TRR-2TIR Hydra magnipapillata 
Asymmetric 
dimer: involves 
BB (molecule 
A), βD, βE, DE, 
αE (molecule 
B); symmetric 
dimer: involves 
αB, αC, αD  
X-ray crystallography 
Weisse & 
Scheidig, 
unpublished; 
PDB ID 
4W8G 
TRR-2TIR:TRR-2TIR Hydra magnipapillata 
Asymmetric 
dimer 1: 
involves BB 
(molecule A), 
βD, βE, DE, αE 
(molecule B); 
asymmetric 
dimer 2: 
involves αA, αE 
(molecule A), 
αB, αC, αD 
(molecule B) 
X-ray crystallography 
Weisse & 
Scheidig, 
unpublished; 
PDB ID 
4W8H 
Plant TIR domains 
L6TIR:L6TIR 
Linum 
usitatissimum 
(flax) 
Symmetric 
dimer:  involves  
αD1, αD3, αE, 
βE , DE, EE 
(DE interface) 
X-ray 
crystallography, 
MALS, analytical 
ultracentrifugation 
(AUC), yeast two-
hybrid (Y2H) analysis 
[17] 
RRS1TIR:RPS4TIR Arabidopsis thaliana 
Pseudo-
symmetric 
dimer: involves 
αA, αE, EE (of 
both RRS1TIR 
and RPS4TIR) 
and DD 
(RRS1TIR) (AE 
interface) 
X-ray 
crystallography, 
MALS , SAXS, Y2H 
analysis 
[18] 
RPS4TIR:RPS4TIR Arabidopsis thaliana 
Symmetric 
dimer: involves 
αA, αE, EE (AE 
interface)  
X-ray 
crystallography, 
MALS, SAXS, AUC, 
Y2H analysis 
[18] 
RRS1TIR:RRS1TIR Arabidopsis thaliana 
Symmetric 
dimer: involves 
αA, αE, EE (AE 
interface) 
X-ray crystallography [18] 
RPV1TIR:RPV1TIR 
Muscadinia 
rotundafolia 
(wild 
grapevine) 
Symmetric 
dimer: involves 
αA, αE, EE (AE 
interface) 
X-ray crystallography [58] 
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SNC1TIR:SNC1TIR Arabidopsis thaliana 
Two dimer 
interfaces; 
interface 1 (AE 
interface), 
involves αA, 
αE, EE; 
interface 2 (DE 
interface): 
involves αD1, 
αE, βE, DE, EE 
X-ray crystallography [59] 
SNC1TIR:SNC1TIR Arabidopsis thaliana 
Two dimer 
interfaces; 
interface 1 (AE 
interface), 
involves αA, 
αE, EE; 
interface 2 (DE 
interface): 
involves αD1, 
αE , βE, DE, EE 
X-ray 
crystallography, 
MALS, SAXS 
[60] 
RPP1TIR:RPP1TIR Arabidopsis thaliana 
Two dimer 
interfaces; 
interface 1 (AE 
interface), 
involves αA, 
αE, EE; 
interface 2 (DE 
interface): 
involves αD1, 
αE , βE, DE, EE 
X-ray 
crystallography, 
MALS  
[60] 
Bacterial TIR domains 
PdTLPTIR:PdTLPTIR Paracoccus denitrificans 
Symmetric 
dimer: involves 
DD, EE  
X-ray 
crystallography, 
hydrogen/deuterium 
exchange mass 
spectrometry 
(DXMS) 
[61] 
TcpBTIR:TcpBTIR Brucella melitensis 
Involves DD, 
EE, αC, αD 
X-ray 
crystallography, 
MALS  
[24] 
TcpBTIR:TcpBTIR Brucella melitensis 
Symmetric 
dimer: involves 
DD, EE  
X-ray 
crystallography, 
SAXS, MALS 
[62] 
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TcpBTIR:TcpBTIR Brucella melitensis 
Symmetric 
dimer: involves 
DD, EE 
X-ray 
crystallography, 
DXMS 
[53] 
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